Immuron IMRN
NASDAQ IMRN
$1.77 -0.07 (-3.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

Immuron (IMRN) Interest & Investment Income (2017 - 2024)

Immuron (IMRN) posted Interest & Investment Income of $2184.0 for Q3 2024, down 97.12% on a QoQ basis from $75725.2 in Q4 2023.

Analysis

Immuron (IMRN) Interest & Investment Income (2017 - 2024) Analysis & Trends

Immuron has reported Interest & Investment Income for 8 years, with the latest figure at $2184.0 in Q3 2024.

  • On a quarterly basis, Interest & Investment Income changed N/A year-over-year to $2184.0 in Q3 2024; TTM through Sep 2024 was $132056.9, a N/A change from a year earlier, with the FY2026 full-year figure at $185438.0, up 13548.59% from the prior year.
  • Interest & Investment Income was $2184.0 for Q3 2024 at Immuron, down from $75725.2 in the prior quarter.
  • The five-year high for Interest & Investment Income was $75725.2 in Q4 2023, with the low at $46.26 in Q4 2020.
  • Average Interest & Investment Income over 5 years is $26420.6, with a median of $2184.0 recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Interest & Investment Income jumped 71296.7% in 2022, then jumped 40.05% in 2023.
  • Over 5 years, Interest & Investment Income stood at $46.26 in 2020, then soared by 63.71% to $75.73 in 2021, then surged by 71296.7% to $54072.0 in 2022, then surged by 40.05% to $75725.2 in 2023, then plunged by 97.12% to $2184.0 in 2024.
  • The last three Interest & Investment Income figures came in at $2184.0 (Q3 2024), $75725.2 (Q4 2023), and $54072.0 (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 120.60 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -48.00 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 48.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 67.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 28.14 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 36.92 Mn
10 Immuron 10.28 Mn 1.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 9, 2024 2,183.95
Dec 31, 2023 75,725.17
Dec 31, 2022 54,072.00
Dec 31, 2021 75.73
Dec 31, 2020 46.26
Dec 31, 2019 2.59
Dec 31, 2018 39.00
Dec 31, 2017 33.07